| Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780) |
|---|
| 04/13/2005 | EP1522580A1 Crystals of an aurora-a tpx2 complex, tpx2 binding site of aurora-a, aurora-a ligands and their use |
| 04/13/2005 | EP1521757A1 Novel tricyclic spiropiperidines or spiropyrrolidines |
| 04/13/2005 | EP1254104B1 Quaternary ammonium compounds and their use as anti-tussive agent |
| 04/13/2005 | EP1200503B1 Process for the polymerisation of cycloolefins and polymerisable cycloolefins |
| 04/13/2005 | CN1606544A Bicyclic compound |
| 04/13/2005 | CN1605587A Fluoro-aromatic organic tetracarboxylic dianhydride and its preparation method and use |
| 04/13/2005 | CN1196497C Near infrared fluorescent contrast agent and fluorescence imaging |
| 04/13/2005 | CN1196484C Medical compositions for combinant use as anticancer atent |
| 04/12/2005 | US6879754 Drop-before-add optical switching and routing system employing grating-based wavelength selective switches |
| 04/12/2005 | US6878739 Composition for treating or preventing glomerulopathy |
| 04/12/2005 | US6878732 5,7-diazaspiro(3.4)octane and -octene derivatives; treating diseases including emesis, depression, anxiety and cough |
| 04/12/2005 | US6878712 E.g., (R)-((2S,5R)-2-methyl-5-methyl-4-(4-carboxyphenyl-sulphonyl)-1-(3,3,3 -trifluoro-2-hydroxy-2-methylpropionyl)-piperazine); antidiabetic agents |
| 04/12/2005 | US6878700 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
| 04/12/2005 | US6878183 Sublimation purifying method and apparatus |
| 04/12/2005 | CA2081836C Aromatic amidine derivatives and salts thereof |
| 04/07/2005 | WO2005030794A2 Hemiasterlin derivatives and uses thereof |
| 04/07/2005 | WO2005030756A1 Substituted pyrrole-indoles as inhibitors of pai-1 |
| 04/07/2005 | WO2005030719A1 Novel method for preparing cis-octahydro-isoindole |
| 04/07/2005 | WO2005030718A1 Novel method of preparing cis-octahydro-isoindole |
| 04/07/2005 | WO2005030717A1 Substituted indole acid derivatives and their use as pai-1 inhibitors |
| 04/07/2005 | WO2005030716A1 Heterocyclic- or aryloxy, -thio or -amino substituted indoles-2-carboxylic acids or esters as pai-1 |
| 04/07/2005 | WO2005030715A1 Substituted sulfonamide-indole-2-carboxylic acid derivatives as pai-1 inhibitors |
| 04/07/2005 | WO2005030714A1 Process for the production of compounds having 5- to 10-membered aromatic heterocycles with alkylmagnesium monoamides |
| 04/07/2005 | WO2005030705A1 Inhibitors of histone deacetylase |
| 04/07/2005 | WO2005030704A1 Inhibitors of histone deacetylase |
| 04/07/2005 | WO2005030702A1 Biphenyloxy-acids |
| 04/07/2005 | WO2005030695A1 Conversion of amine- to carboxyl groups on solid surfaces |
| 04/07/2005 | WO2005030213A1 1,1,1-trifluoro-4-phenyl-4-methyl-2-(1h-pyrrolo |
| 04/07/2005 | WO2005030192A1 4- (1h-indol-3-yl-methylideneaminoxy-propoxy) -benzioc acid derivatives and related compounds as pai-1 inhibitors for the treatment of impairment of the fibrinolytic system and of thrombisis |
| 04/07/2005 | WO2005030191A1 ((((1h-indol-3yl) methylidene)amino)oxy)acetic acid derivatives and related compounds as pai-1 inhibitors for the treatment of inpairement of the fibrinolytic system and of thrombosis |
| 04/07/2005 | WO2005030148A2 Tetrahydroindolone derivatives for treatment of neurological conditions |
| 04/07/2005 | WO2004112718A3 Compounds, compositions and methods for treatment and prevention of orthopoxvirus infections and associated diseases |
| 04/07/2005 | WO2004101530A8 A method for producing diverse set of dithioate compounds |
| 04/07/2005 | WO2004014871A8 Vanilloid receptor ligands and their use in treatments |
| 04/07/2005 | WO2003028728A8 4-(4-substituted piperazinyl-1yl)-butylcarboxamides as d3 dopamine subtype selective ligands |
| 04/07/2005 | US20050075390 HIV protease inhibitors |
| 04/07/2005 | US20050075387 Process for preparing an azabicyclo[3.1.0] hexane compound |
| 04/07/2005 | US20050075378 Modulators of peroxisome proliferator activated receptors (ppar) |
| 04/07/2005 | US20050075367 Ester compound and medicinal use thereof |
| 04/07/2005 | US20050075348 Functionalized heterocycles as modulators of chemokine receptor function and methods of use therefor |
| 04/07/2005 | US20050075344 Melanocortin receptor agonists |
| 04/07/2005 | US20050075332 Tricyclic compounds with antiviral activity |
| 04/07/2005 | US20050074683 Electrophotographic organophotoreceptors with novel charge transport compounds |
| 04/07/2005 | CA2580730A1 Tetrahydroindolone derivatives for treatment of neurological conditions |
| 04/07/2005 | CA2539823A1 Hemiasterlin derivatives and uses thereof |
| 04/07/2005 | CA2539250A1 Biphenyloxy-acids |
| 04/07/2005 | CA2539234A1 ((((1h-indol-3yl) methylidene)amino)oxy)acetic acid derivatives and related compounds as pai-1 inhibitors for the treatment of inpairement of the fibrinolytic system and of thrombosis |
| 04/07/2005 | CA2539117A1 Inhibitors of histone deacetylase |
| 04/07/2005 | CA2538703A1 Substituted indole acid derivatives and their use as pai-1 inhibitors |
| 04/07/2005 | CA2538694A1 Heterocyclic- or aryloxy, -thio or -amino substituted indoles-2-carboxylic acids or esters as pai-1 |
| 04/07/2005 | CA2538355A1 Substituted pyrrole-indoles as inhibitors of pai-1 |
| 04/07/2005 | CA2538263A1 Substituted sulfonamide-indole-2-carboxylic acid derivatives as pai-1 inhibitors |
| 04/07/2005 | CA2538258A1 4- (1h-indol-3-yl-methylideneaminoxy-propoxy) -benzioc acid derivatives and related compounds as pai-1 inhibitors for the treatment of impairment of the fibrinolytic system and ofthrombisis |
| 04/06/2005 | EP1521107A1 Filters for electronic displays |
| 04/06/2005 | EP1520854A2 Aza-Spirocompounds for the treatment of pain |
| 04/06/2005 | EP1520452A2 Electronic devices made with electron transport and/or anti-quenching layers |
| 04/06/2005 | EP1520308A2 Polymeric charge transport compositions and electronic devices made with such compositions |
| 04/06/2005 | EP1520305A2 Charge transport compositions and electronic devices made with such compositions |
| 04/06/2005 | EP1519935A2 Charge transport compositions comprising fluorinated phenanthroline derivatives |
| 04/06/2005 | EP1519932A1 Bisarylsulfonamide compounds and their use in cancer therapy |
| 04/06/2005 | EP1519921A2 Substituted anthranilic amide derivatives and methods of use |
| 04/06/2005 | EP1519919A1 Indolin phenylsulfonamide derivatives |
| 04/06/2005 | EP1519915A2 Tricyclic steroid hormone nuclear receptor modulators |
| 04/06/2005 | EP1519726A1 Utilization of heteroarene carboxamide as dopamine-d3 ligands for the treatment of cns diseases |
| 04/06/2005 | EP1414817B1 substituted isoindoles and the use thereof |
| 04/06/2005 | EP1077700B1 BENZIMIDAZOLE DERIVATIVES AS MODULATORS OF IgE |
| 04/06/2005 | EP0984930B1 2-indolinone derivatives as modulators of protein kinase activity |
| 04/06/2005 | EP0960096B1 Substituted beta-thiocarboxylic acids |
| 04/06/2005 | EP0748219B1 Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis |
| 04/06/2005 | CN1604898A 3-heteroaryl-3, 5-dihydro-4-oxo-4h-pyridazino[4, 5-b]indole-1-carboxamide derivatives, their preparation, their intermediates and pharmaceutical compositions containing the compounds |
| 04/06/2005 | CN1603963A Organophotoreceptor with a charge transport material having at least two azine groups |
| 04/06/2005 | CN1603309A Process for cascade reaction preparation of N-acetyl-DL-tryptophan |
| 04/06/2005 | CN1195752C Processes for producing 7-isoindolinequinolonecarboxylic derivatives and intermediates therefor, solts of 7-isoindo-linequinolonecarboxylic acid, hydrates thereof, and composition contg. same |
| 04/06/2005 | CN1195737C HIV proteinase inhibitor |
| 04/06/2005 | CN1195735C Sulfonylamino derivatives which inhibit matrix-degrading metallopr teinases |
| 04/05/2005 | US6875884 Urea derivatives as inhibitors for CCR-3 receptor |
| 04/05/2005 | US6875875 Process for preparing glycidylphthalimide |
| 04/05/2005 | US6875780 Compounds that modulate PPAR activity and methods for their preparation |
| 04/05/2005 | US6875764 Urea and thiourea compounds useful for treatment of coccidiosis |
| 04/05/2005 | US6875760 Glucagon antagonists/inverse agonists |
| 04/05/2005 | US6875759 Anticancer agents; analgesics |
| 03/31/2005 | WO2005028445A2 Derivatives of n-(1h-indazolyl)- and n-(1h-indolyl)-urea as well as related compounds as modulators of the vanilloid-1 receptor (vr1) for the treatment of pain |
| 03/31/2005 | WO2005028437A1 Process for the preparation of secondary aminoalcohols |
| 03/31/2005 | WO2005028436A2 Thalidomide analogs as tnf-alpha modulators |
| 03/31/2005 | WO2005027837A2 Substituted sulfonamides |
| 03/31/2005 | WO2005027823A2 3-heterocyclyl-indole derivatives as inhibitors of glycogen synthase kinase-3 (gsk-3) |
| 03/31/2005 | WO2005016867A3 Anthranilic acid derivatives and their use as activators of the hm74a receptor |
| 03/31/2005 | WO2005009947A3 Aryl heteroaromatic products, compositions comprising the same and use thereof |
| 03/31/2005 | WO2005005461A3 Novel method for the synthesis of perindopril and the pharmaceutically acceptable salts thereof |
| 03/31/2005 | WO2004113270A3 Propionic acid derivatives useful in the treatment of lipid disorders |
| 03/31/2005 | WO2004099171A3 Substituted amino carboxylic acids as inhibitors of protein tyrosine phosphatase-1b |
| 03/31/2005 | WO2004073606A3 Sulfonamide derivatives as ppar modulators |
| 03/31/2005 | US20050070723 Process for the synthesis of a CPLA2 inhibitor |
| 03/31/2005 | US20050070719 Central nervous system disorders; antidiabetic agents; antiinflammatory agents; antiarthritic agents;obesity; osteoporosis ; anticancer agents |
| 03/31/2005 | US20050070707 [1.2]-Oxazin-3,5-diones |
| 03/31/2005 | US20050070605 Reacting an organophosphouus compound with metallized alkane; forming atorvastatin, lorastatin, pitavastatin, fluvastatin |
| 03/31/2005 | US20050070592 Thrombosis; antiischemic agents; chronic obstructive pulmonary disease; antidiabetic agents; antiarthritic agents ; Alzheimer's disease; anticancer agents; strokes; cardiovascular disorders |
| 03/31/2005 | US20050070582 For example,1-{[2-(3,5-dimethylphenoxy)-5-nitrophenyl]sulfonyl}-4-ethylpiperazine or 1-{[2-(3,5-dichlorophenoxy)-5-nitrophenyl]sulfonyl}piperazine; for the treatment of asthma, atopic dermatitis, allergic rhinitis and other inflammatory/immunological disorders |
| 03/31/2005 | US20050070559 Use of oxindole derivatives in the treatment of dementia related diseases, alzheimer's disease and conditions associated with glycogen synthase kinase-3 |
| 03/31/2005 | US20050069798 comprises electrically conductive substrate and photoconductive element; improved electrostatics; latent imaging |